Literature DB >> 6497649

A method of studying the intestinal absorption of aluminium in the rat.

G B van der Voet, F A de Wolff.   

Abstract

Aluminium (Al) intoxication in dialysis patients is held to be caused not only by Al in the dialysis fluid but also by Al from orally administered phosphate binders. Studies on Al absorption in patients and healthy individuals as well as in animals are still scarce, and do not provide sufficient data to characterize the absorption process. This paper presents a method of studying the process of Al absorption in a perfusion system of rat small intestine in vivo, in combination with a cannulation system of the portal vein for serial blood sampling. Determination of concentrations of an absorbed substance in samples of both the perfusion medium and the portal blood, collected during the perfusion medium and the portal blood, collected during the perfusion period, may clarify the nature of the absorption process. Although this method appears to be useful for the study of the intestinal absorption of any substance, it was adapted for the study of the intestinal absorption of Al compounds. The usefulness of this method for studying Al absorption was demonstrated in an experiment in which Al chloride (0.5 g/l) in buffered media of pH 7.0, 7.5, and 8.0 was perfused through the rat small intestine over a period of at least 30 min. The results of this experiment indicate that a decrease in pH of the perfusion medium leads to an increase in absorption of Al in the portal blood.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6497649     DOI: 10.1007/bf00316122

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  20 in total

1.  Effect of perfusion rate on absorption, surface area, unstirred water layer thickness, permeability, and intraluminal pressure in the rat ileum in vivo.

Authors:  L D Lewis; J S Fordtran
Journal:  Gastroenterology       Date:  1975-06       Impact factor: 22.682

2.  Aluminium retention and toxicity in chronic renal failure.

Authors:  H Thurston; G R Gilmore; J D Swales
Journal:  Lancet       Date:  1972-04-22       Impact factor: 79.321

3.  Intestinal drug absorption and metabolism. I. Comparison of methods and models to study physiological factors of in vitro and in vivo intestinal absorption.

Authors:  W H Barr; S Riegelman
Journal:  J Pharm Sci       Date:  1970-02       Impact factor: 3.534

4.  Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia.

Authors:  M R Wills; J Savory
Journal:  Lancet       Date:  1983-07-02       Impact factor: 79.321

5.  Aluminium toxicity in an infant not on dialysis.

Authors:  M E Randall
Journal:  Lancet       Date:  1983-06-11       Impact factor: 79.321

6.  Dialysis encephalopathy, bone disease and anaemia: the aluminum intoxication syndrome during regular haemodialysis.

Authors:  I S Parkinson; M K Ward; D N Kerr
Journal:  J Clin Pathol       Date:  1981-11       Impact factor: 3.411

7.  Aluminium ion: metabolism and toxicity.

Authors:  G M Berlyne; J E Rubin
Journal:  J Hum Nutr       Date:  1977-12

8.  Aluminum absorption in the rat everted gut sac.

Authors:  M Feinroth; M V Feinroth; G M Berlyne
Journal:  Miner Electrolyte Metab       Date:  1982-07

9.  Modification of polyethylene glycol estimation suitable for use with small mammals.

Authors:  J M Boulter; H B McMichael
Journal:  Gut       Date:  1970-03       Impact factor: 23.059

10.  Dialysis encephalopathy in a non-dialysed uraemic boy treated with aluminium hydroxide orally.

Authors:  E Nathan; S E Pedersen
Journal:  Acta Paediatr Scand       Date:  1980-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.